USNA
Usana Health Sciences Inc

519
Mkt Cap
$342.03M
Volume
195,412.00
52W High
$40.79
52W Low
$18.48
PE Ratio
21.02
USNA Fundamentals
Price
$18.67
Prev Close
$18.71
Open
$18.83
50D MA
$23.65
Beta
0.87
Avg. Volume
368,413.39
EPS (Annual)
$2.19
P/B
0.65
Rev/Employee
$502,648.82
Loading...
Loading...
News
all
press releases
Connor Clark & Lunn Investment Management Ltd. Acquires 65,268 Shares of USANA Health Sciences, Inc. $USNA
Connor Clark & Lunn Investment Management Ltd. boosted its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 202.3% in the second quarter, according to the company in its most...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 2,000 Shares of Stock
USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Frederic Winssinger sold 2,000 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an...
MarketBeat·9d ago
News Placeholder
Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval
Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval PR...
PR Newswire·9d ago
News Placeholder
Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600
Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600 Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap...
PR Newswire·24d ago
News Placeholder
USANA Health Sciences (USNA) Reports Q3 Loss, Misses Revenue Estimates
USANA Health (USNA) delivered earnings and revenue surprises of 0.00% and -0.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
USANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year Outlook
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025. Key Financial Results Third Quarter 2025 vs. Third Quarter 2024 Net...
Business Wire·29d ago
News Placeholder
USANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval--Setting the Standard for Product Quality
USANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval--Setting the Standard for Product Quality USANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of...
PR Newswire·1mo ago
News Placeholder
USANA Health Sciences Provides Preliminary Third Quarter Results
USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately...
Business Wire·1mo ago
News Placeholder
Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?
Aquestive Therapeutics (AQST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·2mo ago
News Placeholder
USNA vs. STVN: Which Stock Is the Better Value Option?
USNA vs. STVN: Which Stock Is the Better Value Option?
Zacks·2mo ago

Latest USNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.